Glycosmedia - an international diabetes news service from the UK
  
 
Archived News
November 25th 2008
 
 
  Psychological Therapy to Improve Control of Type 1 Diabetes
  Combined psychological therapies (motivational enhancement therapy plus cognitive behavior therapy) resulted in clinically relevant improvements in blood sugar control in type 1 diabetes compared with usual care (Annals of Internal Medicine)
   
  The National Diabetes Goal
  By 2015, 45% of Americans who are at risk for type 2 diabetes will know their blood glucose level and what actions to take (National Diabetes Goal, USA)
   
  Diabetes-Drug Makers Face FDA Hurdle
  Concern over reports that link diabetes drugs to heart trouble is compelling U.S. drug regulators to ask diabetes-drug makers for more safety data. These requests for additional data could delay new product approvals by years and add millions of dollars to development and post-market commitment costs (The Street)
   
  JDRF funded research shows promise for preventing and reversing type 1 diabetes
  The researchers used Imatinib and Sunitinib (which are marketed as Gleevec and Sutent respectively) to treat mice that are genetically engineered to be more susceptible to developing type 1 diabetes. These drugs both act by blocking a family of enzymes, called tyrosine kinases, that modify cellular signals and trigger growth (JDRF)
   
  HbA1c as a diagnostic or screening test for diabetes
  Fasting plasma glucose should remain the preferred screening test for diabetes but HbA1c is acceptable as an option (NZSSD)
   
  Cancer drug for diabetes
  Although there are similarities between human diabetes and this mouse model, there may also be differences in the processes underlying the development of the condition. Only human trials will show if the drug would have a similar effect in humans (NHS Choices)
   
  CalorieKing and Joslin Team Up for Diabetes Awareness Month
  The two organizations intend to collaborate on additional online diabetes resources in the future, including a program specifically developed to help individuals with type 2 diabetes better manage their weight and help control their diabetes (Market Watch)
   
 
  
© Copyright Glycosmedia Partnership